Merck to Buy Cubist for 8.4 Billion for Its Antibiotics

Dec 8, 2014, 00:00 by Michael Croft

Businessweek | Merck & Co. agreed to buy Cubist Pharmaceuticals for $8.4 billion in cash to add products to help fight the growing threat of drug-resistant bacteria.

December 08, 2014 | Merck & Co. agreed to buy Cubist Pharmaceuticals for $8.4 billion in cash to add products to help fight the growing threat of drug-resistant bacteria. Businessweek